When is a Ventilation-Perfusion (VQ) scan recommended in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ventilation-Perfusion (VQ) Scan in Pregnancy: Diagnostic Algorithm

In pregnant women with suspected pulmonary embolism (PE), a VQ scan is recommended as the preferred imaging test when chest radiography is normal, due to lower maternal breast radiation exposure compared to CT pulmonary angiography (CTPA). 1

Initial Evaluation and Diagnostic Pathway

  • A chest radiograph (CXR) should be the first radiation-associated procedure in all pregnant women with suspected PE to guide subsequent imaging selection 1, 2
  • For pregnant women with signs and symptoms of deep vein thrombosis (DVT), bilateral compression ultrasound (CUS) of lower extremities should be performed first; if positive, anticoagulation can be initiated without pulmonary imaging 1, 2
  • If CUS is negative or if there are no signs/symptoms of DVT, proceed with chest radiography followed by appropriate pulmonary vascular imaging 1
  • D-dimer testing is not recommended to exclude PE in pregnancy due to poor specificity (D-dimer levels naturally increase during pregnancy) 1, 2

VQ Scan Indications in Pregnancy

  • Normal chest radiograph: VQ scan is strongly recommended as the next imaging test rather than CTPA 1, 2
  • VQ scanning delivers significantly lower radiation dose to maternal breast tissue (0.98-1.07 mGy) compared to CTPA (10-60 mGy) 1
  • The lifetime relative risk of radiation-induced breast cancer in a 25-year-old woman undergoing CTPA is estimated at 1.011, making VQ scan preferable from a maternal cancer risk perspective 1, 2
  • In pregnant women, unlike in non-pregnant populations, VQ scans do not have a higher rate of non-diagnostic results compared to CTPA 1

When CTPA is Preferred Over VQ Scan

  • Abnormal chest radiograph: CTPA is recommended over VQ scan when CXR shows abnormalities 1
  • Non-diagnostic VQ scan: When a VQ scan is non-diagnostic and further investigation is needed, CTPA is recommended rather than digital subtraction angiography 1
  • Centers where VQ scanning is not readily available may use CTPA as an acceptable alternative 1

Safety and Efficacy Considerations

  • Both VQ scanning and CTPA have similar false-negative rates (0.5% and 0.4% respectively) when used in pregnancy 1
  • Although fetal radiation dose may be slightly higher with VQ scanning than with CTPA, both are well below the threshold for fetal radiation exposure concerns 1
  • Studies show that withholding anticoagulation in pregnant women with normal or non-diagnostic VQ scans appears safe, with no reported venous thromboembolic events during follow-up 3, 4
  • Recent data shows that perfusion-only imaging may be a reasonable option for pregnant patients, as the exclusion of ventilation images only minimally increases the rate of positive studies (<1%) 5

Common Pitfalls and Practical Considerations

  • Despite guidelines recommending VQ scans, real-world data shows CTPA remains the most common modality used for PE diagnosis in pregnancy (55.7-70.0% across all trimesters) 6
  • Non-diagnostic CTPA rates are higher in pregnancy compared to VQ scans, primarily due to suboptimal vascular opacification and respiratory motion artifacts 2, 7
  • The positive scan rate for PE in pregnancy is low (3.5% compared to 8.8% in non-pregnant women), highlighting the importance of appropriate patient selection for imaging 7
  • For unstable patients or when imaging studies cannot be promptly obtained, empiric anticoagulation should be considered while awaiting diagnostic results 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.